Dren Bio IncFrench Sanofi SA announced that it will acquire Dren Bio Inc’s bispecific myeloid cell engager DR-0201 for upfront US$600m and US$1.3bn in milestones. The deal is expected to close in Q2/2025.
Tag Archive for: HBM Healthcare Investments
Sphingotec GmbHGerman diagnostics specialist SphingoTec GmbH has closed a €5m Series C financing round led by Think.Health Ventures.